Theorem Clinical Research

Europe

Funding promotes new tools and services in synthetic biology

Monday, December 2, 2013 01:01 PM

Businesses are being invited to develop standard tools and services that will help grow the emerging industry of synthetic biology. Up to $5.1 million is being made available by the Technology Strategy Board, together with the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC) and the Welsh Government.

More... »


Patient involvement increases public confidence in health research studies

Wednesday, November 27, 2013 10:58 AM

An Ipsos MORI survey of 1,295 British adults has shown that public confidence in health research studies can be increased by knowing that patients have participated in advising on the design of the study.

More... »


Boston Scientific system receives CE Mark approval for Dystonia

Tuesday, November 26, 2013 11:38 AM

The Boston Scientific Vercise Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

More... »

ICRC-Weyer, Allied Clinical Management form MEDIS Research Group

Wednesday, November 20, 2013 12:50 PM

CROs ICRC-Weyer and Allied Clinical Management have entered into a strategic partnership to form MEDIS Research Group. The partnership will enable the two CROs to combine clinical research experience and provide complete service solutions across all stages of the clinical development process.

More... »

European Medicines Agency, EUnetHTA publish joint work plan

Wednesday, November 20, 2013 12:47 PM

The European Medicines Agency (EMA) and EUnetHTA, the European network for Health Technology Assessment, have published a joint three-year work plan outlining key areas of collaboration.

More... »

Vect-Horus collaborates with Advanced Accelerator Applications

Wednesday, November 20, 2013 12:42 PM

French company Vect-Horus, which specializes in the development of vector molecules for the central nervous system, has signed a scientific collaboration agreement with Advanced Accelerator Applications(AAA), a European provider of Molecular Nuclear Medicine (MNM). Financial terms were not disclosed.

More... »

Synexus, Northumbria Healthcare partner

Monday, November 18, 2013 01:53 PM

Synexus has partnered with Northumbria HealthcareNHS Foundation Trust to establish a clinical research facility at Hexham General Hospital, in North East England.

More... »

MHRA, BIA call for earlier access to medicines in the U.K.

Monday, November 18, 2013 01:39 PM

Following the publication of the report on innovation in the regulation of healthcare by the Medicines and Healthcare Products Regulatory Agency (MHRA), the BioIndustry Association (BIA) urges the U.K. government to implement a properly funded and reimbursed Earlier Access to medicines Scheme (EAS), which the group makes its number one recommendation.

More... »

Congressman calls for U.S. to join international trial, disease initiatives

Friday, November 15, 2013 01:06 PM

In a speech to the European Commission, U.S. Representative Chaka Fattah of Pennsylvania reiterated American support for international brain research collaboration and pledged his commitment to engaging the U.S. in two E.U.-led initiatives around clinical trials and neurodegenerative diseases.

More... »

Scientists a step closer to developing vaccine against C. difficile

Friday, November 8, 2013 12:10 PM

A group of scientists from across Europe have launched a three-year project aimed at developing an oral vaccine against Clostridium difficile, an infection that kills around 4,000 people a year (almost four-times more than MRSA) and for which there currently is no effective treatments.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs